YESIGHT completes tens of millions of Yuan in Series A financing, led by DELIAN CAPITAL

Recently,YESIGHT (Suzhou) Medical Technology Co., Ltd. (AbbreviationYESIGHTAnnouncementSuccessfully completed tens of millions of yuanARound of financing.This round of financing was led by DELIAN CAPITAL, with the existing shareholder Beijing Qiwo Boxing Management Consulting Co., Ltd. continuing to increase its investment, demonstrating the high level of confidence the capital market has in the development potential of YESIGHT.

YESIGHT has a clear and forward-looking plan for the proceeds from this round of financing.The company stated that it will fully promote the ultra-widefield confocal laser scanning ophthalmoscope (Scanning Laser Ophthalmoscope，SLO) The clinical registration and production progress of the product. The successful implementation of this product is expected to provide a more efficient and precise tool for ophthalmic clinical diagnosis.At the same time, YESIGHT will increase its investment in the research and development of multiple innovative ophthalmic optical devices, continuously consolidating its leading position in the industry. Notably, YESIGHT has completed two rounds of financing in less than a year, a remarkable achievement that undoubtedly demonstrates the capital market's full recognition of its business model, technical strength, and development prospects.

YESIGHT, as an innovative ophthalmic optical equipment platform technology enterprise, covers businesses including research and development, production, sales, andAIBig data research and other aspects, forming a complete and highly competitive industrial chain layout. The company's headquarters is located in Suzhou, China, and with the superior industrial environment and policy support in Suzhou, it provides a solid foundation for the company’s stable development. Additionally, YESIGHT has established a research institute in Japan, fully utilizing Japan's profound heritage and advanced R&D resources in optical technology to promote international technical exchanges and cooperation, enhancing its own technological innovation capabilities.

In terms of technology development, the current team at YESIGHT is focusing on ophthalmic diagnostics.SLODevelopment of Ultra-Widefield Confocal Laser Scanning Fundus Camera Technology. Through relentless efforts, the product parameters have now reached a world-leading level. This achievement marks a significant breakthrough for YESIGHT in the core technology field of ophthalmic optical equipment. Based on confocal laser scanning imaging technology and integrated circuit technology, YESIGHT has successfully developed internationally advanced equipment.SLOUltra-widefield confocal laser scanning ophthalmoscope, along with several innovative diagnostic and screening devices for ophthalmic diseases, has been launched. These products are not only technologically innovative but also meet clinical needs, providing strong support for the early diagnosis and precise treatment of ophthalmic diseases.